Research Article
Safety and Observations in a Pilot Study of Lenalidomide for Treatment in Autism
Table 1
Demographic and TNF-alpha (pg/ml) data for study subjects.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*
1: 1 diluted samples. values represent the results of the differences between baseline values and 6 and 12-month values using the Wilcoxon Signed Ranks Test. |